Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Gains 5%; BSE HEALTHCARE Index Up 0.6%
Tue, 3 Sep 14:8

INDRAPRASTHA MEDICAL Gains 5%; BSE HEALTHCARE Index Up 0.6%Image source: Chunumunu/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has zoomed 5% and is presently trading at Rs 439.4.

Meanwhile, the BSE HEALTHCARE index is at 43,237.8 (up 0.6%).

Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 5.0%) and Sanofi India (up 4.2%).

SUN PHARMA ADV. RES. (down 2.5%) and Pfizer (down 1.7%) are among the top losers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 180.0 to Rs 439.4, registering a gain of Rs 259.4 (up 144.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,871.2 to 43,237.8, registering a gain of 55.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 127.7%), Glenmark Pharma (up 123.3%) and SUVEN PHARMACEUTICALS (up 114.4%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 82,509.1 (down 0.1%).

The top losers among the BSE Sensex today are Bajaj Finance (down 3.0%) and Bajaj Finserv (down 1.4%). The most traded stocks in the BSE Sensex are Kotak Bank and Tata Steel.

In the meantime, NSE Nifty is at 25,264.1 (down 0.1%). Bajaj Finance and IOC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,087.3 to 82,509.1, registering a gain of 17,421.8 points (up 26.8%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 46.8% YoY to Rs 448 million for the quarter ended June 2024, compared to a profit of Rs 305 million a year ago. Net sales rose 13.5% to Rs 3,479 million during the period as against Rs 3,065 million in April-June 2023.

For the year ended March 2023, INDRAPRASTHA MEDICAL reported 47.0% increase in net profit to Rs 862 million compared to net profit of Rs 586 million during FY22. Revenue of the company grew 23.7% to Rs 10,987 million during FY23.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 29.1.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Gains 5%; BSE HEALTHCARE Index Up 0.6%". Click here!